228 related articles for article (PubMed ID: 27808453)
1. Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC
Rodrigo C; Eltahla AA; Bull RA; Luciani F; Grebely J; Dore GJ; Applegate T; Page K; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Shoukry NH; Lauer GM; Maher L; Schinkel J; Prins M; Hellard M; Lloyd AR;
J Viral Hepat; 2017 Jan; 24(1):43-52. PubMed ID: 27808453
[TBL] [Abstract][Full Text] [Related]
2. HCV dispersal patterns among intravenous drug users (IDUs) in Athens metropolitan area.
Papachristou E; Tsagkovits A; Zavitsanou A; Hatzakis A; Paraskevis D
Infect Genet Evol; 2016 Nov; 45():415-419. PubMed ID: 27721034
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.
Zhao R; Peng J; Tang L; Huang H; Liu M; Kong W; Pang B
J Med Virol; 2013 Oct; 85(10):1712-23. PubMed ID: 23868809
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus subtype diversity and transmission clusters characteristics among drug users in Zhuhai, South China.
Li H; Huang H; Huang W; Du M; Long D; Xu G; Mei W; Huang K
BMC Infect Dis; 2024 Apr; 24(1):451. PubMed ID: 38685009
[TBL] [Abstract][Full Text] [Related]
5. Phylogenetic and phylodynamic analyses of hepatitis C virus subtype 1a in Okinawa, Japan.
Hoshino K; Sugiyama M; Date T; Maruwaka S; Arakaki S; Shibata D; Maeshiro T; Hokama A; Sakugawa H; Kanto T; Fujita J; Mizokami M
J Viral Hepat; 2018 Aug; 25(8):976-985. PubMed ID: 29577516
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal.
Calado RA; Rocha MR; Parreira R; Piedade J; Venenno T; Esteves A
J Med Virol; 2011 Apr; 83(4):608-15. PubMed ID: 21328374
[TBL] [Abstract][Full Text] [Related]
7. Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia.
Rodrigo C; Eltahla AA; Bull RA; Grebely J; Dore GJ; Applegate T; Page K; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Schinkel J; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Estes C; Razavi H; Lloyd AR; Luciani F;
J Infect Dis; 2016 Nov; 214(9):1383-1389. PubMed ID: 27571901
[TBL] [Abstract][Full Text] [Related]
8. A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015.
Bartlett SR; Applegate TL; Jacka BP; Martinello M; Lamoury FM; Danta M; Bradshaw D; Shaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J
J Int AIDS Soc; 2019 Feb; 22(2):e25222. PubMed ID: 30746864
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus molecular epidemiology in Uzbekistan.
Kurbanov F; Tanaka Y; Sugauchi F; Kato H; Ruzibakiev R; Zalyalieva M; Yunusova Z; Mizokami M
J Med Virol; 2003 Mar; 69(3):367-75. PubMed ID: 12526047
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan.
Sanders-Buell E; Rutvisuttinunt W; Todd CS; Nasir A; Bradfield A; Lei E; Poltavee K; Savadsuk H; Kim JH; Scott PT; de Souza M; Tovanabutra S
J Med Virol; 2013 Jul; 85(7):1170-9. PubMed ID: 23918535
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.
Oliveira Mde L; Bastos FI; Telles PR; Hacker Mde A; Oliveira SA; Miguel JC; Yoshida CF
J Clin Virol; 2009 Mar; 44(3):200-6. PubMed ID: 19195927
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
Demetriou VL; van de Vijver DA; Hezka J; Kostrikis LG; ; Kostrikis LG
J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of hepatitis C virus core region in moroccan intravenous drug users.
Trimbitas RD; Fayssel N; Serghini FZ; Wakrim L; Khyatti M; Essalhi M; Bellefquih AM; Benani A
J Med Virol; 2016 Aug; 88(8):1376-83. PubMed ID: 26754854
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Hepatitis C Virus (HCV) Envelope Diversification from Acute to Chronic Infection within a Sexually Transmitted HCV Cluster by Using Single-Molecule, Real-Time Sequencing.
Ho CKY; Raghwani J; Koekkoek S; Liang RH; Van der Meer JTM; Van Der Valk M; De Jong M; Pybus OG; Schinkel J; Molenkamp R
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077634
[TBL] [Abstract][Full Text] [Related]
15. The effects of widespread methadone treatment on the molecular epidemiology of hepatitis C virus infection among injection drug users in Hong Kong.
Chan DP; Lee SS; Lee KC
J Med Virol; 2011 Jul; 83(7):1187-94. PubMed ID: 21567422
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology of newly acquired hepatitis C infections in England 2008-2011: genotype, phylogeny and mutation analysis.
May S; Ngui SL; Collins S; Lattimore S; Ramsay M; Tedder RS; Ijaz S
J Clin Virol; 2015 Mar; 64():6-11. PubMed ID: 25728071
[TBL] [Abstract][Full Text] [Related]
17. Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4.
Stoddard MB; Li H; Wang S; Saeed M; Andrus L; Ding W; Jiang X; Learn GH; von Schaewen M; Wen J; Goepfert PA; Hahn BH; Ploss A; Rice CM; Shaw GM
mBio; 2015 Feb; 6(2):e02518. PubMed ID: 25714714
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time.
Samimi-Rad K; Nasiri Toosi M; Masoudi-Nejad A; Najafi A; Rahimnia R; Asgari F; Shabestari AN; Hassanpour G; Alavian SM; Asgari F
Arch Virol; 2012 Oct; 157(10):1959-65. PubMed ID: 22695769
[TBL] [Abstract][Full Text] [Related]
19. Population dynamics of hepatitis C virus subtypes in injecting drug users on methadone maintenance treatment in China associated with economic and health reform.
Zhou S; Cella E; Zhou W; Kong WH; Liu MQ; Liu PL; Ciccozzi M; Salemi M; Chen X
J Viral Hepat; 2017 Jul; 24(7):551-560. PubMed ID: 28092412
[TBL] [Abstract][Full Text] [Related]
20. Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user.
Aitken CK; Tracy SL; Revill P; Bharadwaj M; Bowden DS; Winter RJ; Hellard ME
J Clin Virol; 2008 Apr; 41(4):293-6. PubMed ID: 18242125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
